Elanco Bayer Merger Agreement

By 18 septiembre, 2021Sin categoría

Media contact: Colleen Parr Dekker +1.317.989.7011 colleen_parr_dekker@elanco.com The consent agreement on this matter regulates alleged violations of federal law, which prohibits unfair methods of competition. The attached analysis regarding Aid Public Comment describes both the allegations made in the complaint and the terms of the consent order – embodied in the consent agreement – that would put an end to these allegations. The companies signed a buyout agreement in August 2019. The transaction was completed after fulfilling closing conditions, including obtaining administrative approvals. Bayer`s former Animal Health business employs around 4,400 people and generated sales of $1.57 billion in 2019 ($US 1.9 billion). ABOUT ELANCO Elanco (ELAN: NYSE) is a global animal health company that develops knowledge-based products and services for the prevention and treatment of diseases in food and domestic animals in more than 90 countries. With a 65-year tradition, we are constantly innovating to improve animal health and benefit our customers, while promoting an inclusive, cause-oriented culture for more than 5,800 employees. At Elanco, we are driven by our vision of food and camaraderie that enriches life – all to promote the health of animals, humans and the planet. Learn more about www.elanco.com. Investor Contact: Tiffany Kanaga +1.302.897.0668 kanaga_tiffany@elanco.com Pursuant to Section 6,(f) of the Federal Trade Commission Act, 15 U.S.C. 46(f) and FTC 2.34, 16 CFR 2.34 are advised that the approval agreement start printed page 44081, titled above, containing an order to abstain and accepted subject to final approval, has been made public by the Commission for a period of thirty (30) days.

The following analysis of the agreement, which contains orders of approval to support public comments, describes the terms of the consent agreement and the allegations made in the complaint. An electronic copy of the full text of the acceptance agreement can be found on the FTC`s website (by July 15, 2020) at this address: www.ftc.gov/news-events/commission-actions. While the period of achievement of the acquisition`s cost reduction targets has been influenced by the COVID-19 pandemic, Elanaco still expects synergies of $275 million to $300 million by 2025. As part of the agreement with Elanco, all Bayer Animal Health employees have at least one year of occupational health. ABOUT BAYER Bayer is a global company with core competencies in the fields of life science health and food. Its products and services must benefit citizens by supporting efforts to address the major challenges of a growing and ageing global population. At the same time, the group wants to increase its profitability and create value through innovation and growth. Bayer upholds the principles of sustainability and the Bayer brand stands for trust, reliability and quality worldwide. In the 2018 financial year, the group employed around 117,000 people and had a turnover of 39.6 billion euros. Investments amounted to €2.6 billion and R&D expenditure to €5.2 billion.